Kimia Bioscien.

Kimia_Bioscien.29 Apr 2024

Pharmaceuticals

₹

-0.82 (-1.59%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Kimia Bioscien.

Kimia Bioscien.

Pharmaceuticals

Kimia_Bioscien.29 Apr 2024

₹

-0.82 (-1.59%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
01-Apr-2024	BC	Dear Sir/ Madam, Pursuant to Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirement) Regulations, 2015 this is to inform you that Ms. Mita Namonath Jha ( DIN: 07258314) has tendered he	01-Apr-2024
07-Feb-2024	BC	Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Dear Sir/Madam This is to inform that	14-Feb-2024
01-Nov-2023	BC	Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve This is to inform that a meeting of Board	09-Nov-2023
02-Sep-2023	BC	Pursuant to Regulation 47 of SEBI (LODR) 2015, we are enclosing herewith the copies notice of 30th AGM of the Company published in the newspapers. The meeting of Board of Directors of the Company	30-Sep-2023
09-Sep-2023	BC	Pursuant to Regulation 30 and 34 of SEBI (LODR) 2015, kindly find enclosed herewith notice of 30th AGM of the Members of the Company.	24-Sep-2023

No Rights has been declared by Kimia_Bioscien.

Book Closure

Record Date	Split Date	Purpose
01-Apr-2024	-	Dear Sir/ Madam, Pursuant to Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirement) Regulations, 2015 this is to inform you that Ms. Mita Namonath Jha ( DIN: 07258314) has tendered he
14-Feb-2024	-	Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Dear Sir/Madam This is to inform that
09-Nov-2023	-	Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve This is to inform that a meeting of Board
30-Sep-2023	-	Pursuant to Regulation 47 of SEBI (LODR) 2015, we are enclosing herewith the copies notice of 30th AGM of the Company published in the newspapers. The meeting of Board of Directors of the Company
24-Sep-2023	01 Jan'1900	Pursuant to Regulation 30 and 34 of SEBI (LODR) 2015, kindly find enclosed herewith notice of 30th AGM of the Members of the Company.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Kimia Biosciences Ltd ₹50.78(-0.82/-1.59%)	50.78	-0.82	240.25	43.93	0.00	622.95
Astrazeneca Pharma India Ltd ₹5,556.10(+140.70/2.60%)	5,556.10	+140.70	13,890.25	71.09	87.09	21.21
Bliss GVS Pharma Ltd ₹124.45(+1.85/1.51%)	124.45	+1.85	1,302.88	60.79	19.09	1.33
Cipla Ltd ₹1,407.55(-1.85/-0.13%)	1,407.55	-1.85	113,644.88	54.54	34.56	4.39
Abbott India Ltd ₹26,277.60(+412.75/1.60%)	26,277.60	+412.75	55,839.90	15.87	48.74	17.96
Amrutanjan Health Care Ltd ₹709.40(+28.55/4.19%)	709.40	+28.55	2,050.92	13.21	46.61	7.83

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	26.14	24.20	24.23	22.66	28.80	40.47
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	26.14	24.20	24.23	22.66	28.80	40.47
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.58	0.64	0.13	0.36	0.26	0.13
Total Income	26.72	24.84	24.36	23.03	29.07	40.60
Total Expenditure	27.19	26.16	25.87	29.08	31.76	39.79
PBIDT	-0.47	-1.32	-1.51	-6.05	-2.69	0.81
Interest	1.31	1.12	1.28	1.26	1.05	1.10
PBDT	-1.78	-2.44	-2.79	-7.31	-3.74	-0.29
Depreciation	0.82	0.82	0.83	0.87	0.84	0.82
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.65	-0.82	-0.91	-2.01	-1.12	-0.29
Reported Profit After Tax	-1.95	-2.44	-2.71	-6.17	-3.46	-0.83
Extra-ordinary Items	0.00	0.00	0.00	-1.05	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.95	-2.44	-2.71	-5.12	-3.46	-0.83

EPS (Unit Curr.)	-0.41	-0.52	-0.57	-1.30	-0.73	-0.18
EPS (Adj) (Unit Curr.)	-0.41	-0.52	-0.57	-1.30	-0.73	-0.18
Calculated EPS (Unit Curr.)	-0.41	-0.52	-0.57	-1.30	-0.73	-0.18
Calculated EPS (Adj) (Unit Curr.)	-0.41	-0.52	-0.57	-1.30	-0.73	-0.18
Calculated EPS (Ann.) (Unit Curr.)	-1.65	-2.06	-2.29	-5.21	-2.93	-0.70
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-1.65	-2.06	-2.29	-5.21	-2.93	-0.70
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.73	4.73	4.73	4.73	4.73	4.73
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-1.80	-5.45	-6.23	-26.70	-9.34	2.00
PBDTM(%)	-6.81	-10.08	-11.51	-32.26	-12.99	-0.72
PATM(%)	-7.46	-10.08	-11.18	-27.23	-12.01	-2.05

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.73	4.73	4.73	4.73	2.11	2.11
Reserves Total	0.73	10.16	13.71	8.64	2.03	-1.79
Equity Share Warrants	0.00	0.00	0.00	0.00	1.97	1.97
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	5.46	14.89	18.44	13.37	6.11	2.29
Secured Loans	28.53	20.06	26.33	16.15	6.04	4.35
Unsecured Loans	24.39	20.55	18.60	17.77	24.57	29.14
Total Debt	52.92	40.61	44.93	33.92	30.61	33.49
Total Liabilities	58.38	55.50	63.37	47.29	36.72	35.78
APPLICATION OF FUNDS :
Gross Block	45.93	44.19	34.45	22.32	19.09	14.74
Less : Accumulated Depreciation	12.30	8.96	6.08	4.47	2.94	1.84
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	33.63	35.23	28.37	17.85	16.15	12.90
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.61	0.00	5.77	5.74	1.53	2.48
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.06	0.06	0.06	0.42	0.01	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	48.23	37.02	23.69	20.31	16.10	9.59
Sundry Debtors	30.59	30.20	41.77	37.33	29.12	29.50
Cash and Bank	0.50	0.52	1.67	0.77	1.26	2.03
Loans and Advances	3.36	5.27	4.66	2.12	1.05	1.64
Total Current Assets	82.68	73.01	71.79	60.53	47.54	42.76
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	54.29	45.58	34.31	28.98	23.91	21.91
Provisions	0.03	0.05	0.05	0.04	0.03	0.01
Total Current Liabilities	54.31	45.63	34.37	29.02	23.94	21.93
Net Current Assets	28.37	27.38	37.42	31.51	23.59	20.83
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	5.84	2.48	0.75	1.16	0.00	0.00
Deferred Tax Liability	1.87	1.57	1.19	1.16	0.00	0.05
Net Deferred Tax	3.97	0.91	-0.44	0.00	0.00	-0.05
Total Assets	66.64	63.58	71.18	55.52	41.28	36.15
Contingent Liabilities	0.12	0.12	0.12	0.12	0.12	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.20	0.59	0.23	0.09	0.55
Net Cash from Operating Activities	-6.77	8.00	5.97	0.31	-2.65
Net Cash Used In Investing Activities	-2.80	-0.71	-13.60	-8.63	-2.22
Net Cash Used In Financing Activities	9.54	-7.67	7.99	8.46	4.42
Net Inc./Dec In Cash And Cash Equivalents	-0.03	-0.38	0.35	0.14	-0.46
Cash And Cash Equivalents At End Of The Year	0.18	0.20	0.59	0.23	0.09

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

74.94%

FII Shareholding

0.00%

DII Shareholding

0.38%

Public Shareholding

24.68%

**Promoter pledged shareholding 74.94%

About Kimia Biosciences Ltd

Kimia Biosciences Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 240.25 crores. It has reported a sales of Rs. 26.14 crores and a net profit of Rs. -1.95 crores for the quarter ended December 2018. The company management includes Sameer Goel, Sameer Goel,Jagdeep Dhavvan,Richa Gupta,Vipul Goel,Lakshay Prakash (Kimia Biosciences Ltd) among others.

Chairman

Sameer Goel

Registered office

Bhondsi Village,Tehsil Sohna,Gurgaon,Haryana,122102

FAX :

Background

Incorporation Year1993

Face Value₹1

Market Lot1

How to buy Kimia Bioscien. shares on nse?

To buy Kimia Bioscien. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Kimia Bioscien. share price today?

The Kimia Bioscien. shares price on nse is Rs.50.78 today.

What is the market cap of Kimia Bioscien. shares on BSE ?

The company has a market capitalization of Rs.240.25Cr

What is the PE & PB ratio of Kimia Bioscien. shares ?

PE is 0 and PB is 622.95

What is the 52 Week High and Low of Kimia Bioscien. shares?

Kimia Bioscien. stock price high: Rs.58.4 Kimia Bioscien. stock price low: Rs.31.99